Patent details

EP2068822 Title: SELF PRESERVED AQUEOUS PHARMACEUTICAL COMPOSITIONS

Basic Information

Publication number:
EP2068822
PCT Application Number:
US2007079082
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078429149
PCT Publication Number:
WO2008036847
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SELF PRESERVED AQUEOUS PHARMACEUTICAL COMPOSITIONS
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES AQUEUSES AUTO-CONSERVÉES
German Title of Invention:
SICH SELBST KONSERVIERENDE WÄSSRIGE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
20/09/2007
Grant date:
02/11/2011
EP Publication Date:
17/06/2009
PCT Publication Date:
27/03/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/06/2009
EP B1 Publication Date:
02/11/2011
EP B2 Publication Date:
27/07/2022
EP B3 Publication Date:
Lapsed date:
20/09/2023
Expiration date:
20/09/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/07/2022
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

History of Owners

From:
12/12/2019
To:
12/12/2019

Name:
ALCON RESEARCH, LLC
Address:
6201 South Freeway, 76134, Fort Worth, TX, United States (US)

From:
20/09/2007
To:
12/12/2019

Name:
Alcon Research Ltd.
Address:
6201 South Freeway, Mail Code TB4-9, Fort Worth, TX 76134-2099, United States (US)

Inventor

1

Name:
CHOWHAN, Masood A.
Address:
United States (US)

2

Name:
HAN, Wesley Wehsin
Address:
United States (US)

3

Name:
SCHNEIDER, L. Wayne
Address:
United States (US)

4

Name:
KABRA, Bhagwati P.
Address:
United States (US)

Priority

1

Priority Number:
826529 P
Priority Date:
21/09/2006
Priority Country:
United States (US)

2

Priority Number:
827411 P
Priority Date:
28/09/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 47/02; A61K 47/10; A61K 47/26;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2020/01
Publication date:
13/01/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2020/01
Publication date:
13/01/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202230
Publication date:
27/07/2022
Description:
Patent maintained (B2 publication)

2

Issue number:
201849
Publication date:
05/12/2018
Description:
Title of invention Modified

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20190000456A
Date Registered:
12/12/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Fusion-Absorption
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
ALCON RESEARCH, LLC
Address:
6201 South Freeway, 76134, Fort Worth, TX, United States (US)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20190000456B
Date Registered:
12/12/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Novartis AG
Address:
., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/09/2022
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
24/11/2023 General Document 2
24/12/2019 Outgoing Correspondence 1
12/12/2019 Request For Change 9